Child Kidney Dis.  2017 Apr;21(1):26-30. 10.3339/jkspn.2017.21.1.26.

A Contrast Nephropathy in a Preterm Infant Following Preoperative Embolization of Giant Sacrococcygeal Teratoma

Affiliations
  • 1Department of Pediatrics University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. mdleebs@amc.seoul.kr

Abstract

Newborn infants with huge and highly vascular sacrococcygeal teratoma (SCT) are frequently subjected to renal hypoperfusion secondary to high-output cardiac failure. Any underlying renal dysfunction is a significant risk factor for the development of contrast-induced nephropathy (CIN). However, reports on CIN in infants are rare. I report here a case of a premature infant born at 28 weeks and 3 days of gestation with a huge SCT who survived preoperative embolization and surgical resection but presented with persistent non-oliguric renal failure that was suggestive of CIN. During radiological intervention, a contrast medium had been administered at about 10 times the manufacturer-recommended dose for pediatric patients. Despite hemodynamic stabilization and normalization of urine output immediately following surgery, the patient's serum creatinine and cystatin-C levels did not return to baseline until 4 months after birth. No signs of reflux nephropathy were observed in follow-up imaging studies. Dosing guidelines for the use of a contrast medium in radiological interventions should be provided for infants or young patients.

Keyword

Acute kidney injury; Contrast-induced nephropathy; Sacrococcygeal teratoma; Premature infant; Therapeutic embolization

MeSH Terms

Acute Kidney Injury
Creatinine
Embolization, Therapeutic
Follow-Up Studies
Heart Failure
Hemodynamics
Humans
Infant
Infant, Newborn
Infant, Premature*
Parturition
Pregnancy
Renal Insufficiency
Risk Factors
Teratoma*
Creatinine
Full Text Links
  • CKD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr